Dr Wu has been with the Group since 2011. He was appointed Chief Product Officer in June 2017 and is responsible for overseeing the product management for the Group, and coordinating the product innovation, development and commercialisation of the Group’s portfolio.
He joined Clearbridge Biomedics Pte Ltd, in 2011, and was responsible for leading the product development and commercialisation of cancer diagnostic products as a project director. He subsequently held the position of general manager from 2012 to 2016, and chief operating officer from 2016 to 2017. Prior to joining Clearbridge Biomedics Pte Ltd, from 2007 to 2011, he was the technical director of Life Corporation Services (S) Pte Ltd, and was responsible for managing the company’s stem cell banking laboratories.
Dr Wu was conferred with a Bachelor of Engineering in Biochemical Engineering and a Doctor of Philosophy in Biochemical Engineering from the University College London in 2002 and 2008, respectively. He is an affiliate member of the American Society of Clinical Oncology.